Hepatobiliary MRI Contrast Agents: Pattern Recognition Approach to Pediatric Focal Hepatic Lesions.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32182093.
- Also identified by DOI 10.2214/AJR.19.22239.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
<b>OBJECTIVE.</b> The purposes of this article are to review currently available hepatobiliary contrast agents, discuss techniques for optimization of pediatric liver MRI with hepatobiliary contrast agents, and review the imaging features of several pediatric hepatic lesions, focusing on their assessment with hepatobiliary contrast agents. <b>CONCLUSION.</b> MRI is the preferred imaging modality for complete assessment of focal liver lesions in the pediatric population. Imaging with gadolinium-based hepatobiliary contrast agents yields beneficial information about many focal liver lesions encountered in pediatric patients.
Medical subject headings
- Contrast Media
- Gadolinium DTPA
- Liver Diseases
- Magnetic Resonance Imaging
- Meglumine
- Organometallic Compounds